Hana Študentová (Hana Studentova)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Locally Advanced

Metastatic Renal Cell Carcinoma

Top Venues

Expert review of anticancer therapy

Future oncology (London, England)

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Hana Študentová, Katerina Hola, Bohuslav Melichar, Martina Spisarova
Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Expert review of anticancer therapy 24 (6) (2024)
Hana Študentová, Katerina Hola, Bohuslav Melichar, Martina Spisarova
Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Expert review of anticancer therapy 24 (6) (2024)
Hana Študentová, Katerina Hola, Bohuslav Melichar, Martina Spisarova
Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Expert review of anticancer therapy (2024)
Hana Študentová, Katerina Hola, Bohuslav Melichar, Martina Spisarova
Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Expert review of anticancer therapy 24 (6) (2024)
Hana Študentová, Katerina Hola, Bohuslav Melichar, Martina Spisarova
Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Expert review of anticancer therapy (2024)
Hana Študentová, Martina Spisarova, Andrea Kopova, Anezka Zemankova, Bohuslav Melichar, Vladimir Student
The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma. Cancers 15 (15) (2023)
Nikol Rusarova, Denisa Vitaskova, Hana Kalabova, Andrea Ondruskova, Dana Purova, Bohuslav Melichar, Hana Študentová
The role of carboplatin in combination with paclitaxel in patients with castration-resistant prostate cancer. Future oncology (London, England) (2022)
Nikol Rusarova, Denisa Vitaskova, Hana Kalabova, Andrea Ondruskova, Dana Purova, Bohuslav Melichar, Hana Študentová
The role of carboplatin in combination with paclitaxel in patients with castration-resistant prostate cancer. Future oncology (London, England) 18 (38) (2022)
Robert Jirásko, Jakub Idkowiak, Denise Wolrab, Aleš Kvasnička, David Friedecký, Krzysztof Polański, Hana Študentová, Vladimír Študent, Bohuslav Melichar, Michal Holčapek
Altered Plasma, Urine, and Tissue Profiles of Sulfatides and Sphingomyelins in Patients with Renal Cell Carcinoma. Cancers 14 (19) (2022)
Nikol Rusarova, Denisa Vitaskova, Hana Kalabova, Andrea Ondruskova, Dana Purova, Bohuslav Melichar, Hana Študentová
The role of carboplatin in combination with paclitaxel in patients with castration-resistant prostate cancer. Future oncology (London, England) 18 (38) (2022)
Hana Študentová, Nikol Rusarova, Andrea Ondruskova, Anezka Zemankova, Vladimir Student, Daniela Skanderova, Bohuslav Melichar
The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature. Current oncology (Toronto, Ont.) 29 (8) (2022)
Hana Študentová, Anezka Zemankova, Martina Spisarova, Daniela Skanderova, Zbynek Tudos, Bohuslav Melichar, Vladimir Student
A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma. Medicina (Kaunas, Lithuania) 58 (3) (2022)
Hana Študentová, Jindriska Volakova, Martina Spisarova, Anezka Zemankova, Kvetoslava Aiglova, Tomas Szotkowski, Bohuslav Melichar
Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature. BMC gastroenterology 22 (1) (2022)
Nikol Rusarova, Denisa Vitaskova, Hana Kalabova, Andrea Ondruskova, Dana Purova, Bohuslav Melichar, Hana Študentová
The role of carboplatin in combination with paclitaxel in patients with castration-resistant prostate cancer. Future oncology (London, England) 18 (38) (2022)
Radka Obermannova, Iveta Selingerová, Zdenek Rehak, Vaclav Jedlicka, Marek Slavik, Pavel Fabian, Ivo Novotny, Milada Zemanova, Hana Študentová, Peter Grell, Lenka Zdrazilova Dubska, Regina Demlova, Tomas Harustiak, Renata Hejnova, Igor Kiss, Rostislav Vyzula
PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study. Therapeutic advances in medical oncology 13 (2022)